Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

被引：6

作者：

Richter, Julia ^{[1
]}

Huettmann, Andreas ^{[2
]}

Rekowski, Jan ^{[3
]}

Schmitz, Christine ^{[2
]}

Gartner, Selina ^{[4
]}

Rosenwald, Andreas ^{[5
]}

Hansmann, Martin-Leo ^{[6
]}

Hartmann, Sylvia ^{[6
]}

Moeller, Peter ^{[7
]}

Wacker, Hans-Heinrich ^{[8
]}

Feller, Alfred ^{[9
]}

Thorns, Christoph ^{[10
]}

Mueller, Stefan ^{[11
]}

Duehrsen, Ulrich ^{[2
]}

Klapper, Wolfram ^{[1
]}

机构：

[1] Univ Hosp Schleswig Holstein, Dept Hematopathol, Kiel, Germany

[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, Essen, Germany

[3] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany

[4] HTG Mol Diagnost Inc, Tucson, AZ 85706 USA

[5] Univ Wurzburg, Dept Pathol, Wurzburg, Germany

[6] Univ Hosp Frankfurt, Dept Pathol, Frankfurt, Germany

[7] Univ Hosp Ulm, Dept Pathol, Ulm, Germany

[8] Inst Hamatopathol, Kiel, Germany

[9] Hamatopathol Lubeck, Lubeck, Germany

[10] Univ Hosp Schleswig Holstein, Dept Pathol, Lubeck, Germany

[11] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, Essen, Germany

来源：

BLOOD CANCER JOURNAL | 2019年 / 9卷 / 9期

基金：

芬兰科学院;

关键词：

CLASSIFICATION; PROGNOSIS;

D O I：

10.1038/s41408-019-0230-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 11 条

[1] Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].

Chapuy, Bjoern ;

Stewart, Chip ;

Dunford, Andrew J. ;

Kim, Jaegil ;

Kamburov, Atanas ;

Redd, Robert A. ;

Lawrence, Mike S. ;

Roemer, Margaretha G. M. ;

Li, Amy J. ;

Ziepert, Marita ;

Staiger, Annette M. ;

Wala, Jeremiah A. ;

Ducar, Matthew D. ;

Leshchiner, Ignaty ;

Rheinbay, Ester ;

Taylor-Weiner, Amaro ;

Coughlin, Caroline A. ;

Hess, Julian M. ;

Pedamallu, Chandra S. ;

Livitz, Dimitri ;

Rosebrock, Daniel ;

Rosenberg, Mara ;

Tracy, Adam A. ;

Horn, Heike ;

van Hummelen, Paul ;

Feldman, Andrew L. ;

Link, Brian K. ;

Novak, Anne J. ;

Cerhan, James R. ;

Habermann, Thomas M. ;

Siebert, Reiner ;

Rosenwald, Andreas ;

Thorner, Aaron R. ;

Meyerson, Matthew L. ;

Golub, Todd R. ;

Beroukhim, Rameen ;

Wulf, Gerald G. ;

Ott, German ;

Rodig, Scott J. ;

Monti, Stefano ;

Neuberg, Donna S. ;

Loeffler, Markus ;

Pfreundschuh, Michael ;

Truemper, Lorenz ;

Getz, Gad ;

Shipp, Margaret A. .

NATURE MEDICINE, 2018, 24 (05) :679-+

[2] MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study [J].

Copie-Bergman, Christiane ;

Cuilliere-Dartigues, Peggy ;

Baia, Maryse ;

Briere, Josette ;

Delarue, Richard ;

Canioni, Danielle ;

Salles, Gilles ;

Parrens, Marie ;

Belhadj, Karim ;

Fabiani, Bettina ;

Recher, Christian ;

Petrella, Tony ;

Ketterer, Nicolas ;

Peyrade, Frederic ;

Haioun, Corinne ;

Nagel, Inge ;

Siebert, Reiner ;

Jardin, Fabrice ;

Leroy, Karen ;

Jais, Jean-Philippe ;

Tilly, Helve ;

Molina, Thierry Jo ;

Gaulard, Philippe .

BLOOD, 2015, 126 (22) :2466-2474

[3] Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma [J].

Cottereau, Anne-Segolene ;

Lanic, Helene ;

Mareschal, Sylvain ;

Meignan, Michel ;

Vera, Pierre ;

Tilly, Herve ;

Jardin, Fabrice ;

Becker, Stephanie .

CLINICAL CANCER RESEARCH, 2016, 22 (15) :3801-3809

[4] Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles [J].

Cunningham, David ;

Hawkes, Eliza A. ;

Jack, Andrew ;

Qian, Wendi ;

Smith, Paul ;

Mouncey, Paul ;

Pocock, Christopher ;

Ardeshna, Kirit M. ;

Radford, John A. ;

McMillan, Andrew ;

Davies, John ;

Turner, Deborah ;

Kruger, Anton ;

Johnson, Peter ;

Gambell, Joanna ;

Linch, David .

LANCET, 2013, 381 (9880) :1817-1826

[5] Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial [J].

Duehrsen, Ulrich ;

Mueller, Stefan ;

Hertenstein, Bernd ;

Thomssen, Henrike ;

Kotzerke, Joerg ;

Mesters, Rolf ;

Berdel, Wolfgang E. ;

Franzius, Christiane ;

Kroschinsky, Frank ;

Weckesser, Matthias ;

Kofahl-Krause, Dorothea ;

Bengel, Frank M. ;

Duerig, Jan ;

Matschke, Johannes ;

Schmitz, Christine ;

Poeppel, Thorsten ;

Ose, Claudia ;

Brinkmann, Marcus ;

La Rosee, Paul ;

Freesmeyer, Martin ;

Hertel, Andreas ;

Hoeffkes, Heinz-Gert ;

Behringer, Dirk ;

Prange-Krex, Gabriele ;

Wilop, Stefan ;

Krohn, Thomas ;

Holzinger, Jens ;

Griesshammer, Martin ;

Giagounidis, Aristoteles ;

Raghavachar, Aruna ;

Maschmeyer, Georg ;

Brink, Ingo ;

Bernhard, Helga ;

Haberkorn, Uwe ;

Gaska, Tobias ;

Kurch, Lars ;

van Assema, Danielle M. E. ;

Klapper, Wolfram ;

Hoelzer, Dieter ;

Geworski, Lilli ;

Joeckel, Karl-Heinz ;

Scherag, Andre ;

Bockisch, Andreas ;

Rekowski, Jan ;

Huettmann, Andreas .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) :2024-+

[6] Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].

Hans, CP ;

Weisenburger, DD ;

Greiner, TC ;

Gascoyne, RD ;

Delabie, J ;

Ott, G ;

Müller-Hermelink, HK ;

Campo, E ;

Braziel, RM ;

Jaffe, ES ;

Pan, ZG ;

Farinha, P ;

Smith, LM ;

Falini, B ;

Banham, AH ;

Rosenwald, A ;

Staudt, LM ;

Connors, JM ;

Armitage, JO ;

Chan, WC .

BLOOD, 2004, 103 (01) :275-282

[7] Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma [J].

Horn, H. ;

Ziepert, M. ;

Wartenberg, M. ;

Staiger, A. M. ;

Barth, T. F. E. ;

Bernd, H-W ;

Feller, A. C. ;

Klapper, W. ;

Stuhlmann-Laeisz, C. ;

Hummel, M. ;

Stein, H. ;

Lenze, D. ;

Hartmann, S. ;

Hansmann, M-L ;

Moeller, P. ;

Cogliatti, S. ;

Pfreundschuh, M. ;

Truemper, L. ;

Loeffler, M. ;

Glass, B. ;

Schmitz, N. ;

Ott, G. ;

Rosenwald, A. .

LEUKEMIA, 2015, 29 (07) :1564-1570

[8] Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma:: SUV-based assessment versus visual analysis [J].

Lin, Chieh ;

Itti, Emmanuel ;

Haioun, Corinne ;

Petegnief, Yolande ;

Luciani, Alain ;

Dupuis, Jehan ;

Paone, Gaetano ;

Talbot, Jean-Noel ;

Rahmouni, Alain ;

Meignan, Michel .

JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (10) :1626-1632

[9] Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma [J].

Schmitz, R. ;

Wright, G. W. ;

Huang, D. W. ;

Johnson, C. A. ;

Phelan, J. D. ;

Wang, J. Q. ;

Roulland, S. ;

Kasbekar, M. ;

Young, R. M. ;

Shaffer, A. L. ;

Hodson, D. J. ;

Xiao, W. ;

Yu, X. ;

Yang, Y. ;

Zhao, H. ;

Xu, W. ;

Liu, X. ;

Zhou, B. ;

Du, W. ;

Chan, W. C. ;

Jaffe, E. S. ;

Gascoyne, R. D. ;

Connors, J. M. ;

Campo, E. ;

Lopez-Guillermo, A. ;

Rosenwald, A. ;

Ott, G. ;

Delabie, J. ;

Rimsza, L. M. ;

Wei, K. Tay Kuang ;

Zelenetz, A. D. ;

Leonard, J. P. ;

Bartlett, N. L. ;

Tran, B. ;

Shetty, J. ;

Zhao, Y. ;

Soppet, D. R. ;

Pittaluga, S. ;

Wilson, W. H. ;

Staudt, L. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (15) :1396-1407

[10]

Thiele J., 2018, WHO classification of tumours of haematopoietic and lymphoid tissues, V4th

← 1 2 →